Skip to main content

Tinnitech International is an Italian start-up founded by a group of high-profile investors and managers who have developed a ground-breaking device delivering the first multiple therapy to treat tinnitus (clinically defined as “synchronous multimodal therapy”) based on a versatile, effective and long-lasting remedy.

Our members

Luciano Grottola

President & Partner Entrepreneur in the medical sector.
Vice-President of Farmindustria; President of Assinde; President of Ecupharma Srl.

Giancarlo Migliori

Managing Partner Entrepreneur in the technology sector.
Expert in Innovation and IP Management, former Managing Partner of “Tecnologie Strutturate” (Structured Technologies, a specialist Tech&IP advisory)

Petrone Group

Investor, Medical Sector “Fin Posillipo S.p.A. – holding company of the Petrone group. The company operates globally in the field of pharmaceutical distribution and production. With a turnover of about 537 million, it has a direct presence on the national market of Italy, in Spain, Ireland, Singapore, the United States, Germany and Portugal.”

PFM Summary

Operating Investor Holding, Medical SectorPFM Sintesi, present in 12,000 Italian pharmacies, in recent years has undertaken an expansion strategy through investments in companies with global solutions and high economic and competitive potential.

Monetti SPA

Financial holding investor, medical sector Over 40 years of activity in the export and distribution of pharmaceutical products on a European scale; purchase of pharmaceutical molecules, research and development of food supplements. Turnover of 250 million, 300 between employees and advisors, 50,000 square metres of warehousing.

Pier Vincenzo Colli

Investor Manager 40 years of experience within Healthcare & Pharma companies. He has held top positions in multinationals such as IQVIA, PHARMACIA-UPJHON, NYCOMED, TAKEDA.
For the last 10 years he has been CEO of leading Italian group ALFASIGMA. He is currently a strategic consultant and private equity investor in the Healthcare/Biopharmaceutical sector.

Clinical Partners

Financial Partner